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LITERATURE REVIEW

Serum Ammonia and Folate Levels:
Opportunities for High Value Care
R. Benson Jones Jr. MD, Sean Dikdan MD, and Bracken Babula, MD

High value care encompasses a variety of principles
including ordering tests with high diagnostic yield, while
reducing low value practices. Two tests that are
frequently ordered but rarely contribute meaningfully to
the diagnosis and management of patients are serum
ammonia levels and serum folate levels. The American
Association for the Study of Liver Disease (AASLD)
recommends against using blood ammonia levels for
hepatic encephalopathy (HE), stating that the test does
not add “any diagnostic, staging, or prognostic value”
for patients with chronic liver disease1. The American
Society for Clinical Pathology (ASCP) in the Choosing
Wisely campaign by the American Board of Internal
Medicine recommended considering “folate supplementation instead of serum folate testing in patients
with macrocytic anemia2.” In the following discussion,
we will discuss the evidence behind these claims in
addition to our own argument against routinely ordering
serum ammonia and serum folate levels in the
assessment of hepatic encephalopathy and anemia,
respectively. We will also provide a preliminary analysis
of the cost related to these tests and the potential
impact of changing ordering practices at our institution,
a large urban academic medical system.

Serum Ammonia Levels in the Assessment
of Hepatic Encephalopathy
HE is a brain dysfunction caused by liver pathology,
portosystemic shunting, or both. It manifests in a wide
spectrum of neurological and psychiatric abnormalities
and is typically a clinical diagnosis using the West Haven
Criteria (WHC) classification system1. Because 85% of
ammonia is detoxified by the liver and excreted as urea
in urine (with muscle and brain tissue metabolizing the
rest), it has been theorized that hyperammonemia
contributes to HE 3 . Astrocytes synthesize more
glutamine in the setting of increased ammonia,
precipitating reactive oxygen species, astrocyte
swelling, and enhanced gamma-aminobutryic acid
(GABA) inhibition, manifesting as cerebral dysfunction.
In addition, bleeding, infection, and renal failure all
precipitate HE and incidentally promote hyperammonemia. With these underlying factors in mind, it
would appear that ammonia levels would be helpful in
the diagnosis of HE. Multiple issues with serum
ammonia, however, limit its usefulness. Fist clenching,
the use of a tourniquet during the process of
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phlebotomy and processing time can lead to false
elevations or spurious results 4-6. The sensitivity and
specificity of a venous ammonia greater than 55
µmol/L) to diagnose HE were 47.2% and 78.4%,
respectively. In one study, 60% of the patients with
grade 3 HE by the West Haven Criteria had a normal
serum ammonia level 7. These test characteristics
underlie the AASLD recommendation to avoid checking
serum ammonia in patients with chronic liver disease
to diagnose or assess the severity of HE. Covert HE (i.e.
Grade I HE by WHC) remains a diagnostic challenge
given the lack of reproducibility of clinical findings, but
trivial lack of awareness, shortened attention span, and
altered sleep rhythm can raise suspicion for this
diagnosis in patients with liver disease.

Institutional ordering characteristics and associated
healthcare charges for serum ammonia
Between the initial date of data recording (11/25/2016) to
the day the database was accessed (1/14/2020), there
were a total of 7541 serum ammonia orders. Of these
orders, 6206 orders occurred in the inpatient setting,
with a charge of $201 per order according to the publicly
available institutional chargemaster8 (Figure 1). Note that
these charges do not reflect what the patient pays;
insurance companies dictate how much reimbursement
the institution receives. The average dollar amount of
charges per month attributable to inpatient serum
ammonia orders alone is $31,984.76, calculated by
dividing the total charge amount for all serum ammonia
orders over the examined time ($1,247,406) by the
number of months of data (39 months). The departments
who ordered the most serum ammonia levels are
Medicine (2404 orders total), Emergency Medicine in the
flagship hospital (1702), and Emergency Medicine in a
nearby community hospital (702) (Figure 2).

Serum Folate Levels in the Assessment
of Anemia
Folic acid (folate) is a critical water-soluble B vitamin
used in the process of DNA synthesis. Deficiency of
folate manifests in newborns as neural tube defects
and classically as macrocytic, megaloblastic anemia in
adults. In an effort to reduce the incidence of neural
tube defects, the US government began mandating
supplementation of every 1 gram of grain with 140 mcg
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Figure 1

Outpatient vs. Inpatient Ammonia Orders
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Figure 2
Ammonia orders by location
Ammonia orders by location
Medical ICU

540

Medical ICU

540

Neurology

785

Neurology

785

Emergency Med (Community)

772

Emergency Med (Community)

Institutional ordering characteristics and associated
healthcare charges for serum folate

772

Emergency Med (Flagship)

1702

Emergency Med (Flagship)

1702

Medicine

2404

Medicine

2404

0

500

0

500

1000

1500

2000

2500

3000

1000

1500

2000

2500

3000

Figure 3
Total B12 and Folate vs. Folate Alone (All Medicine orders in Green)
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With the same criteria as the prior analysis, there were
43,932 total serum folate and combined serum folate
and vitamin B12 orders. Of these orders, 7193 were
serum folate alone. The Department of Medicine ordered
33,451 (76.1%) of the total orders (Figure 3). The total
charge per month for serum folate orders was estimated
to be between $28,161.53 and $233,177.53 using the $25
charge from commercial laboratory and the $207 charge
from the institutional chargemaster to generate the
range. Note that the $25 charge is a direct cost to the
patient, while the $207 is the charge submitted to
insurance companies.
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has its own innate flaws. Although the microbiologic
assay for serum folate is more accurate and the gold
standard, the competitive protein binding assay is more
frequently used due to its relative technical ease.
Unfortunately this protein binding assay has a coefficient
of variance between samples from the same individuals
of 21.5% 11. Finally, the cost of treatment of folate
deficiency is orders of magnitude less expensive than
the assay itself: 400 mcg folate tablets range from $0.03
per tablet to $0.20 cents per tablet, while the charge for
the folate assay ranges from $25 in outpatient assistance
programs from commercial laboratory corporations to
$207 by the institutional chargemaster8, 12 (Serum folate
assay pricing, LabCorp © and Quest Diagnostics
Customer Service, phone call, 1/14/2020). Thus, when
a macrocytic anemia and the suspicion for an isolated
folate deficiency is high (malabsorptive issues, prior GI
surgery, prolonged malnutrition), it is reasonable to
initiate folate supplementation and to recheck a
complete blood count in 4 weeks to see if the MCV and
anemia has changed13.
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of folic acid in 1996, leading to a 36% reduction in the
prevalence of neural tube defects in the US.9 This
fortification has led to a significant decline in prevalence
of adult folate deficiency. In an analysis of the National
Health and Nutrition Examination Survey (NHANES)
study group, Pfeiffer and colleagues found that “the
percentage of the population with low serum folate (<3
ng/mL) declined from 21% in the period before
fortification (1988--1994) to <1% of the total population
in the period immediately following fortification 10
(1999--2000)." Despite low prevalence of folate
deficiency clinicians continue to order the assay, which
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Serum ammonia and serum folate levels should not be
routinely ordered in the diagnosis and management of
hepatic encephalopathy or in the diagnosis of anemia,
respectively. Chargemaster charges and simple numerical
counts of orders shows a significant charge burden for
tests that do not significantly impact patient care. While
this analysis does not provide cost estimates to the
institution as a whole as it does not incorporate assay
costs and lab personnel processing time, it reveals the
charges that minimal utility tests impose on the healthcare
system. One proposal to reduce ordering folate levels is
to replace the combined folate/B12 order with individual
folate and B12 orders in physician preference lists. Future
work will assess the impact of iterative changes on the
reduction of these orders and strive to understand the
cost of these assays to the institution.

The Medicine Forum, Volume 21 | 29 5

2

Jones et al.: Serum Ammonia and Folate Levels

REFERENCES
1. American Association for the Study of Liver Diseases; European Association for
the Study of the Liver. Hepatic encephalopathy in chronic liver disease: 2014
practice guideline by the European Association for the Study of the Liver and
the American Association for the Study of Liver Diseases [published correction
appears in J Hepatol. 2015 Oct;63(4):1055]. J Hepatol. 2014;61(3):642–659.
doi:10.1016/j.jhep.2014.05.042.
2. American Society for Clinical Pathology. Choosing Wisely – Promoting
conversations between providers and patients (Recommendation 19). https://
www.choosingwisely.org/societies/american-society-for-clinical-pathology/.
Published October 19, 2017. Accessed February 25, 2020.
3. Jacob Ninan, MD, Leonard Feldman, MD, SHFM, FACP, FAAP, Ammonia Levels and
Hepatic Encephalopathy in Patients with Known Chronic Liver Disease. J. Hosp.
Med 2017;8;659-661. doi:10.12788/jhm.2794.
4. Stahl J. Studies of the Blood Ammonia in Liver Disease: Its Diagnostic, Prognostic
and Therapeutic Significance. Ann Intern Med. 1963;58:1–24.
5. Da Fonseca-Wollheim F. Preanalytical increase of ammonia in blood specimens
from healthy subjects. Clin Chem. 1990;36:1483-1487.
6. Howanitz JH, Howanitz PJ, Skrodzki CA, Iwanski JA. Influences of specimen
processing and storage conditions on results for plasma ammonia. Clin Chem.
1984;30:906-908.
7. Gundling F, Zelihic E, Seidl H, et al. How to diagnose hepatic encephalopathy in
the emergency department. Ann Hepatol. 2013;12:108-114.
8. Hospital Charges - What Are We Talking About? (General - Thomas Jefferson
University Hospital). Hospital Charges - What Are We Talking About? - Jefferson
University Hospitals. https://hospitals.jefferson.edu/patients-and-visitors/chargedescription-master.html. Accessed January 14, 2020.
9. National Birth Defects Prevention Network. Neural tube defect ascertainment
project 2010. Available at http://www.nbdpn.org/current/resources/ntd_fa_info.
html. Accessed January 30, 2019.
10. Pfeiffer CM, Johnson CL, Jain RB, et al. Trends in blood folate and vitamin B-12
concentrations in the United States, 1988-2004. Am J Clin Nutr 2007;86:718--27.
11. Gilfix BM. Utility of measuring serum or red blood cell folate in the era of
folate fortification of flour. Clin Biochem. 2014;47(7-8):533–538. doi:10.1016/j.
clinbiochem.2014.01.023.
12. 1-48 of 814 results for "folate supplement". Amazon.com. https://www.amazon.
com/s?k=folate supplement&s=price-asc-rank&crid=CN4FP799PMZZ&qid=1582
513010&sprefix=folate,aps,136&ref=sr_st_price-asc-rank. Accessed January 14,
2020.
13. Breu AC, Theisen-Toupal J, Feldman LS, Serum and Red Blood Cell Folate Testing.
J. Hosp. Med 2015;11;753-755. doi:10.1002/jhm.2385.

Volume
21 52020
30 | The
Published
by Medicine
JeffersonForum,
Digital
Commons,

3

